SeaGen SGNS40-002

Study Information

Status: Active, Recruiting

Study Details

View study details on clinicaltrials.gov.

Locations

San Francisco

Clinical Trial FAQs

Information for patients and study volunteers, including frequently asked questions.

Description

An Open-label, Phase 2 Basket Study of SEA-CD40 Combination Therapies in Advanced Malignancies

Location: CPMC (San Francisco)

Please contact: ClinicalResearch@sutterhealth.org about study SeaGen SGNS40-002

Principal Investigator

Kevin Kim, MD

Related Studies

The Impact of Smoking, Comorbidities, and Race/Ethnicity on COVID-19 Infection and Disease Severity

Using EHR from a large healthcare system in Northern CA, we will study the impact of smoking, comorbidities, race on COVID-19 infection and disease severity.

Investigator: Jiang Li, Ph.D., MPH

The Sutter Health Network of Care

Expertise to fit your needs

Primary Care

Check-ups, screenings and sick visits for adults and children.

Specialty Care

Expertise and advanced technologies in all areas of medicine.

Emergency Care

For serious accidents, injuries and conditions that require immediate medical care.

Urgent Care

After-hours, weekend and holiday services.

Walk-In Care

Convenient walk-in care clinics for your non-urgent health needs.